|
Fortis Healthcare’s diabetic foot trial broadens it’s inclusion criteria to include more patients in it’s stem cell study. The study will be evaluating peripheral blood stem cells and their effectiveness in healing diabetic foot ulcers, specifically in patients with poor blood flow (ischemia). A pilot study of similar design in China showed promising results. Ulcerations [...]
|
Write a comment:
|